Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis

Abstract Currently available rabies post‐exposure prophylaxis (PEP) for use in humans includes equine or human rabies immunoglobulins (RIG). The replacement of RIG with an equally or more potent and safer product is strongly encouraged due to the high costs and limited availability of existing RIG....

Descripció completa

Dades bibliogràfiques

Autors principals:	Paola De Benedictis, Andrea Minola, Elena Rota Nodari, Roberta Aiello, Barbara Zecchin, Angela Salomoni, Mathilde Foglierini, Gloria Agatic, Fabrizia Vanzetta, Rachel Lavenir, Anthony Lepelletier, Emma Bentley, Robin Weiss, Giovanni Cattoli, Ilaria Capua, Federica Sallusto, Edward Wright, Antonio Lanzavecchia, Hervé Bourhy, Davide Corti
Format:	Artigo
Idioma:	Inglês
Publicat:	Springer Nature 2016-03-01
Col·lecció:	EMBO Molecular Medicine
Matèries:	human monoclonal antibody lyssaviruses post‐exposure prophylaxis rabies
Accés en línia:	https://doi.org/10.15252/emmm.201505986
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!